Aldosterone antagonists destabilize the mineralocorticosteroid receptor
- PMID: 1313229
- PMCID: PMC1130843
- DOI: 10.1042/bj2820697
Aldosterone antagonists destabilize the mineralocorticosteroid receptor
Abstract
To elucidate the mechanism of action of aldosterone antagonists, we studied the interaction of spironolactone with the chick mineralocorticosteroid receptor (MR). Intestinal cytosol contains specific spironolactone-binding sites (Kd approximately 3 nM; max. no. of binding sites approximately 100 fmol/mg of protein) that have been identified as MRs by competition experiments with steroid ligands and with the monoclonal anti-idiotypic antibody H10E that interacts with aldosterone-binding domain of the MR. Binding studies indicate that aldosterone and spironolactone bind to the MR through a common site that encompasses the epitope recognized by H10E. At 4 degrees C, spironolactone dissociates much more rapidly from the cytosol 8-9 S form of MR (t1/2 38 min) than does aldosterone (t1/2 3240 min). A high dissociation rate was also observed for progesterone, a natural aldosterone antagonist (t1/2 84 min). The covalent linkage of the 90 kDa heat shock protein (hsp90) to the ligand-binding subunit of MR with dimethyl pimelimidate did not notably modify the rate of dissociation of spironolactone from the receptor (t1/2 96 min), excluding the possibility that the rapid dissociation rate of the antagonist was related to hsp90 release. The effects of aldosterone and the two anti-mineralocorticosteroids on the 8-9 S heterooligomeric structure of the MR differed strikingly. Using low-salt density-gradient centrifugation analysis, aldosterone-labelled receptors were recovered as 8-9S complexes, whereas 4 S entities were detected after spironolactone and progesterone binding. This indicated that, under the experimental conditions used, aldosterone antagonists facilitate hsp90 release and thus do not stabilize the non-DNA-binding 8-9S form of MR. We propose that the combination of rapid dissociation of the ligand and a weakened hsp90-receptor interaction is involved in the anti-mineralococorticosteroid activity of aldosterone antagonists.
Similar articles
-
Differences between aldosterone and its antagonists in binding kinetics and ligand-induced hsp90 release from mineralocorticosteroid receptor.J Steroid Biochem Mol Biol. 1992 Mar;41(3-8):815-21. doi: 10.1016/0960-0760(92)90430-q. J Steroid Biochem Mol Biol. 1992. PMID: 1314085
-
Mineralocorticosteroid receptor of the chick intestine. Oligomeric structure and transformation.J Biol Chem. 1989 Jun 5;264(16):9304-9. J Biol Chem. 1989. PMID: 2542305
-
Characterization of human mineralocorticosteroid receptor expressed in the baculovirus system.Proc Natl Acad Sci U S A. 1991 Dec 1;88(23):10681-5. doi: 10.1073/pnas.88.23.10681. Proc Natl Acad Sci U S A. 1991. PMID: 1660146 Free PMC article.
-
Towards selectively modulating mineralocorticoid receptor function: lessons from other systems.Mol Cell Endocrinol. 2004 Mar 31;217(1-2):151-65. doi: 10.1016/j.mce.2003.10.044. Mol Cell Endocrinol. 2004. PMID: 15134814 Review.
-
Mineralocorticoid receptor ligands: biochemical, pharmacological, and clinical aspects.Med Res Rev. 1991 Nov;11(6):617-39. doi: 10.1002/med.2610110604. Med Res Rev. 1991. PMID: 1662327 Review. No abstract available.
Cited by
-
Corticosteroid receptor antagonists: a current perspective.Pharm World Sci. 1995 Mar 24;17(2):31-41. doi: 10.1007/BF01875052. Pharm World Sci. 1995. PMID: 7795556 Review.
-
Aldosterone antagonists in the treatment of hypertension and target organ damage.Curr Hypertens Rep. 2001 Jun;3(3):240-8. doi: 10.1007/s11906-001-0046-2. Curr Hypertens Rep. 2001. PMID: 11353575 Review.
-
Differential intracellular localization of human mineralocorticosteroid receptor on binding of agonists and antagonists.Biochem J. 1994 Aug 15;302 ( Pt 1)(Pt 1):191-7. doi: 10.1042/bj3020191. Biochem J. 1994. PMID: 8068005 Free PMC article.
-
Characterization of the interaction of the human mineralocorticosteroid receptor with hormone response elements.Biochem J. 1993 Jun 1;292 ( Pt 2)(Pt 2):577-83. doi: 10.1042/bj2920577. Biochem J. 1993. PMID: 8389140 Free PMC article.
-
Involvement of the N-terminal region of the human mineralocorticoid receptor hormone-binding domain in agonist and antagonist binding as revealed by a new monoclonal antibody.Biochem J. 1997 May 15;324 ( Pt 1)(Pt 1):57-63. doi: 10.1042/bj3240057. Biochem J. 1997. PMID: 9164841 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources